wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52598812-98871DCF-1CE3-4C92-8FC4-7D1F18DE2C53
Q52598812-98871DCF-1CE3-4C92-8FC4-7D1F18DE2C53
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52598812-98871DCF-1CE3-4C92-8FC4-7D1F18DE2C53
First- and second-line bevacizumab in ovarian cancer: A Belgian cost-utility analysis.
P2860
Q52598812-98871DCF-1CE3-4C92-8FC4-7D1F18DE2C53
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52598812-98871DCF-1CE3-4C92-8FC4-7D1F18DE2C53
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
52907567ed33a3ae6334c9cebb314a5c42697b69
P2860
Patient preferences in advanced or recurrent ovarian cancer.